291 (PB071) - Improved binding affinity and pharmacokinetics enables sustained degradation of BCL6 in vivo
| Autor: | Harnden, A., Huckvale, R., Cheung, K.M., Davis, O., Pierrat, O., Talbot, R., Box, G., Bright, M., Akpinar, A., Miller, D., Hayes, A., Gunnell, E., Le Bihan, Y.V., Burke, R., Kirkin, V., Van Montfort, R., Raynaud, F., Rossanese, O., Bellenie, B., Hoelder, S. |
|---|---|
| Zdroj: | In European Journal of Cancer October 2022 174 Supplement 1:S104-S104 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect